Subscribe to Entrepreneur for $5

Top Stock Picks for Week of September 20, 2021

An Innovative Leader in Advertising and a Restaurant Stock Showing Great Resilience.

This story originally appeared on Zacks

The Trade Desk, Inc. TTD is a provider of technology platform for advertising. Their programmatic platform which enables all ad buyers to set up algorithms based on customer data and targeting -- and then have the program bid for ad space, in real-time, across the web and connected-TV.  The Trade Desk recently delivered an EPS beating the Zacks Consensus Estimate. TTD posted revenues for Q2, surpassing the Zacks Consensus Estimate also. After the report and conference call, analysts moved their EPS targets much higher. In addition to highlighting the launch of their new service Solimar, on the conference call TTD also revealed that in the second half of the year, Walmart will launch a new DSP, which integrates Walmart shopper data and is built on Trade Desk's platform. 

- Zacks

YUM! Brands, Inc. YUM is the global leader in multi-branding and offers consumers more choice and convenience at one outlet. Yum Brands’ shares have outperformed the industry in the past six months. Notably, continued focus on off-premise channels, strategic investments in digital technology and refranchising efforts bode well. Also, it is benefiting from robust sales momentum in North America, the U.K., and Australia. Meanwhile, Yum Brands has implemented various digital features in mobile and online platforms across all brand segments to enhance guest experience. Also, it continues to innovate core menus to attract customers. Earnings estimates for 2021 have moved up in the past 30 days, depicting analyst’s optimism regarding the stock growth potential.The company’s comps rose by double digits in the reported quarter against the year-ago quarter’s decline. Its operating margin was up by double digits year over year also.  

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


Yum Brands, Inc. (YUM): Free Stock Analysis Report


The Trade Desk Inc. (TTD): Free Stock Analysis Report


To read this article on click here.


Zacks Investment Research